fda compounding glp-1 enforcement news today 2025 Congress Introduces SAFE Drugs Act of 2025, Expanding Oversight of Compounded Drugs and Telehealth Providers FDA Offers Clarification on Compounded

Sanyal AJ, Bedossa P, Fraessdorf M, Neff GW, Lawitz E, Bugianesi E, Anstee QM, Hussain SA, Newsome PN, Ratziu V, Hosseini-Tabatabaei A, Schattenberg JM, Noureddin M, Alkhouri N, Younes R

Note also that the compounding market tightened in 2025 to 2026 after the FDA removed semaglutide and tirzepatide from shortage, so pharmacy access to compounded products now generally requires a documented clinical rationale

Check your calendar, have you actually applied 4+ times per week for 6 full weeks

Studied extensively in dermatological and regenerative research for its effects on collagen synthesis, wound repair, and skin remodeling pathways

This approach helps ensure both ADHD and anxiety are supported safely and effectively

In addition, IgAN patients show a decreased relative abundance of Bifidobacterium , which negatively correlates with proteinuria and hematuria levels, suggesting that a reduction in Bifidobacterium abundance is associated with IgAN severity [141]